Roman Butler Fullerton & Co’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,867
Closed -$654K 260
2025
Q1
$654K Buy
+3,867
New +$654K 0.25% 98